Here are relevant reports on : intelligent-landscape-design-market
-
CAR T-Cell Therapy Market by Product (Abecma, Breyanzi, Carvykti, Yescarta, Tecartus, Kymriah), Target (CD19, BCMA), Indication (Multiple Myeloma, Leukemia, Lymphoma), Demographic (Adult, Pediatric), Region, Competitive Landscape - Global Forecast to 2031
The global CAR T-cell therapy market, valued at USD 5.98 billion in 2025, stood at USD 6.78 billion in 2026 and is projected to advance at a resilient CAGR of 14.9% from 2026 to 2031, culminating in a forecasted valuation of USD 13.56 billion by the end of the period. The global CAR T-cell therapy market is growing due to rapid technological advances alongside rising investments from large pharma and well-funded biotech's.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Healthcare IT Solutions Market by Product (EHR, PACS, Interoperability, Healthcare Analytics, Telemedicine, CRM), Market Size, Adoption Trends, Competitive landscape (Market Share Analysis, Product Portfolio Assessment) - Global Forecast to 2020
The global healthcare IT solutions market size is projected to grow at a CAGR of 13.4%. This market is mainly driven by the increasing need to curtail healthcare expenditure and growing demand for solutions to increase the quality of care. The growing patient burden on healthcare systems across the globe and subsequent need to improve operational efficiency is also driving the greater adoption of HCIT solutions among healthcare providers.
- Published: August 2016
- Price: $ 4950
- TOC Available:
-
Active Pharmaceutical Ingredients (API) Market by type (Innovative, Generic), Synthesis (synthetic, biotech), Potency (HPAPI), Product (mAbs, hormones), Drug (OTC, Rx), Application (Diabetes, Oncology), Competitive landscape - Global forecast to 2030
The global active pharmaceutical ingredient market, valued at US$136.22 billion in 2024, stood at US$144.20 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2024 to 2030, culminating in a forecasted valuation of US$198.39 billion by the end of the period. The growth of the active pharmaceutical ingredients market is driven by the surge in demand for complex APIs, such as high-potency API, peptides, oligonucleotides, and increasing government incentives and supply chain reshoring.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035
The global biosimilars market, valued at US$32.75 billion in 2024, stood at US$35.04 billion in 2025 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2035, culminating in a forecasted valuation of US$72.29 billion by the end of the period. This growth is driven by several key factors, including a rising number of regulatory approvals and product launches, the patent expiries of major biologics, and the increasing prevalence of chronic diseases that require effective and affordable treatment options.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Neurostimulation Market by Product & Applications (2012-2017) (Spinal Cord, Deep Brain, Sacral Nerve, Vagus Nerve, Transcranial Magnetic, Gastric, TENS) Global Trends, Emerging Applications & Competitive Landscape
This report provides an in-depth review of the numerous significant developments in neurostimulation technology, and the markets for this technology. It also provides in detail the competitive landscape, profiles of key players and over 100 market related tables on the neurostimulation sector.
- Published: September 2009
- Price: $ 4950
- TOC Available:
-
Network Traffic Analysis & Management Market - Global Worldwide Market Forecasts (2013 - 2018) - Advanced Technologies, Geographical Analysis, Competitive Landscape
The difficulty in correlating end-users identities, as well as IP addresses from network traffic patterns is driving companies such as Cisco, Citrix & Plixer among others to develop advanced network traffic analysis solutions.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Ophthalmology Drugs & Devices Market (Contact Lens, Optical Coherence Tomography (OCT) Scanner, IOL, Dry Eye, AMD, Glaucoma & Phacoemulsification) – Competitive Landscape & Global Forecasts To 2017
The global ophthalmology market witnessed a dip during the economic downturn in 2008 and 2009; however, it is poised to grow at a stable rate mainly due to an increasing aging population, large pool of patients with eye diseases, changing demographics and geographical trends, and increased focus on combination therapies of drugs. Moreover, incidences of glaucoma and cataract are increasing every year.
- Published: August 2012
- Price: $ 4950
- TOC Available:
-
Fertigation & Chemigation Market by Agri Inputs (Fertilizers, Herbicides, Insecticides, & Fungicides), Application (Agriculture, Landscape, & Greenhouse), Crop Type, Irrigation Systems, & by Region - Global Trends and Forecast to 2020
The fertigation & chemigation market, in terms of value, is projected to reach around USD 42.2 Billion by 2020, at a CAGR of around 6.3% from 2015. The fertigation & chemigation market continues to grow due to high demand in most of the countries and intensive market opportunities. The market players are responding to these new opportunities by expanding their global presence and product lines. Fertigation & chemigation, on the basis of agri inputs, has been segmented into: fertilizer, herbicide, insecticide, and fungicide.
- Published: February 2016
- Price: $ 4950
- TOC Available:
-
Vital Signs Monitoring Market - Landscape Analysis of Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices - Forecasts up to 2018
The word “vital” connotes the most significant requirement for sustaining healthy life. Blood pressure, respiratory rate, heart rate and body temperature within a normal range are necessary for the survival of human life and these parameters are referred to as vital signs.
- Published: August 2013
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Offering (Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)), Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030
The global CRISPR market, valued at US$2.90 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$5.47 billion by the end of the period. The growing demand for CRISPR-based gene therapies, followed by advancements in CRISPR technology, and the rising government and private investments in CRISPR technology support the market growth. The development of new vaccines for the treatment of genetic diseases and the expansion of industrial and agricultural applications are presenting strong growth opportunities for CRISPR in the coming years.
- Published: May 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
